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Developmental dysplasia of the hip (DDH) is a wide-spectrum disease with a multifactorial etiology 
and,  despite its prevalence,  no deﬁnitive etiology has yet been established.  The aim of this study was 
to investigate new risk factors for DDH by evaluating newly deﬁned potential risk factors.  A total of 
71 infants were separated into 2 groups: Group I,  28 female ﬁrst-born infants diagnosed with DDH and 
their mothers; and Group II,  43 healthy female ﬁrst-born infants and their mothers.  The maternal 
height and weight before pregnancy,  infant height and weight at birth,  and body mass index (BMI) of 
both mother and infant were determined.  Calculations were made of the ratios between these param-
eters.  Of the examined risk factors,  only maternal height and the ratio of maternal height to infant 
BMI (MH/I-BMI) were found to be signiﬁcant for DDH in infants.  In conclusion,  the results of this 
study show that a short maternal height and a low MH/I-BMI increase the risk of DDH.  Further stud-
ies with a larger series are necessary to conﬁrm these results.
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evelopmental dysplasia of the hip (DDH) is a 
common congenital abnormality that aﬀects the 
developing hip joint of the newborn [1].  The reported 
incidence of DDH varies from 1.5 to 2.5 per 1,000 live 
births [2,  3].  DDH represents a spectrum of hip joint 
disorders,  ranging from hip dysplasia to irreducible 
hip dislocation [4,  5].  The etiology of DDH remains 
unclariﬁed though several theories have been pro-
posed,  including inheritance,  mechanical or environ-
mental factors,  hormone-induced joint laxity,  and 
primary acetabular dysplasia [6].
　 A number of deformities are associated with DDH,  
including neuromuscular fetal abnormalities such as 
arthrogryposis,  calcaneovalgus,  and plagiocephaly.  In 
addition,  swaddling of newborns with hips extended 
and adducted,  breech presentation,  twin pregnancy,  
oligohydramnios,  and positive familial history have 
been associated with DDH.  A 5 : 1 female dominance 
has been noted,  and ligamentous laxity and maternal 
relaxin hormone levels have also been implicated [7,  
8].
　 The aim of the present study was to investigate the 
height,  weight,  and body mass index (BMI) of both the 
infant and the mother in addition to the known factors 
for DDH and thereby identify and assess newly deﬁned 
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potential risk factors in a group of infants with DDH 
in comparison to a control group.  The hypothesis of 
this study was that a larger infant born to a mother of 
small stature could be a predictive factor.
Materials and Methods
　 Using data in hospital admission databases,  we 
determined that a total of 203 DDH patients were 
treated at 2 institutions (the workplaces of authors 1 
and 3) between January 2009 and January 2014.  The 
IRB approval number of this study was 
B.10.4.İSM.4.06.68.49/.  To eliminate any gender bias,  
only ﬁrst-born female infants (age,  2 months - 5 years) 
and their mothers (age at ﬁrst delivery,  20-35 years) 
were included in both the test and control groups.  The 
inclusion criteria also stipulated full-term infants in 
both groups.  Group I consisted of 28 mothers and 
their infants who had been treated for DDH following 
a diagnosis based on ultrasonography (Graf Typeｧ2c) 
or radiography.
　 Exclusion criteria were male gender,  risk factors 
for DDH such as oligohydramnios,  breech presenta-
tion,  multiple pregnancy,  transverse presentation,  
known congenital abnormalities of the fetus,  a strong 
family history including parents,  siblings,  grandpar-
ents and ﬁrst cousins,  torticollis,  postural or con-
genital talipes equinovarus,  congenital talipes calca-
neovalgus,  metatarsus adductus and swaddling.  In 
addition,  neonates with neuromuscular or syndromic 
causes of dislocation (meningomyelocele,  cerebral 
palsy),  or teratologic dislocation,  were excluded as 
the hip abnormality was secondary rather than pri-
mary and therefore not deﬁned as true DDH.  Infants 
in poor overall condition or who had been admitted to 
the Neonatal Intensive Care Unit were also excluded.
　 Group II,  the control group,  consisted of 43 con-
secutive mothers and healthy infants,  who had pre-
sented at the pediatric out-patient clinic between July 
1,  2014 and August 31,  2014.  The infants and moth-
ers were evaluated to ensure that they met the inclu-
sion criteria of full-term,  ﬁrst-born healthy female 
infant aged between 2 months and 5 years,  with no 
DDH (according to the hip ultrasonography screening 
data of patients) or any of the other known risk fac-
tors mentioned above,  and no congenital abnormali-
ties (talipes equinovarus,  torticollis,  meningomyelo-
cele).
　 The following data were taken from patient 
records: maternal height (MH) (cm),  maternal weight 
before pregnancy (MW-BP) (kg),  infant height at birth 
(IH-B) (cm) and infant weight at birth (IW-B) (g).  BMI 
values were calculated for both mother and infant.  
Calculations were then made of the following 
proportions: maternal weight/maternal height (MW/
MH),  infant weight/infant height (IW/IH),  infant 
BMI/maternal BMI (I-BMI/M-BMI),  maternal height/
infant height (MH/IH),  and maternal height/infant 
BMI (MH/I-BMI),  and the results were compared 
between the 2 groups.
　 Statistical analyses were calculated using the 
SPSS 17.0 statistical software (SPSS for Windows,  
SPSS Inc.,  Chicago,  IL,  USA).  Continuous variables 
with normal distribution were compared between 
groups using the Studentʼs t-test,  and those with non-
normal distribution using the Mann-Whitney U test.  
The odds ratios (ORs) for all parameters were calcu-
lated using univariate logistic regression analysis,  and 
the Shapiro-Wilk test was used for tests of normality.  
Power analysis was applied to parameters found to be 
statistically signiﬁcant.  A value of p＜0.05 was con-
sidered statistically signiﬁcant.
Results
　 The results for both groups are summarized in 
Table 1.  The parameters stated above were analyzed 
between the 2 groups.  The average MH was calcu-
lated as 161 (range,  157.25-166.50) cm in Group I and 
164 (160-168) cm in Group II,  and the diﬀerence 
between the groups was found to be statistically sig-
niﬁcant (p＝0.022).  The average MH/I-BMI was cal-
culated as 12.31 (11.37-12.92) in Group I and 12.77 
(12.12-13.79) in Group II,  and the diﬀerence between 
the groups was found to be statistically signiﬁcant 
(p＝0.038).  No statistically signiﬁcant diﬀerences 
were determined in any other parameters and the 
ratios were similar between the 2 groups (all p values
＞0.05).  The ORs for the risk factors are shown in 
Table 2.  The MH OR was calculated as 0.90 (082-
0.99; 95ｵ conﬁdence interval,  CI) for Group I,  
which was statistically signiﬁcant (p＝0.027).  The OR 
for MH/I-BMI was 0.67 (0.46-0.9; 95ｵ CI) for 
Group I,  which was also statistically signiﬁcant 
(p＝0.044).  Power analysis was applied to the statis-
tically signiﬁcant parameters and the powers of MH 
350 Acta Med.  Okayama　Vol.  69,  No.  6Atalar et al.
and MH/I-BMI were determined to be 0.54 and 0.44,  
respectively.  MH and MH/I-BMI were found to have 
a strong association with DDH.  An increase of 1cm in 
maternal height was found to decrease the risk of 
DDH 1.1 fold (1/0.90) and an increase of 1 point in 
MH/I-BMI was found to decrease the DDH risk 1.49 
fold (1/0.67).
Discussion
　 The etiology of DDH is complex since hormonal,  
genetic and mechanical factors may contribute to the 
deformity of the developing hip joint [9].  Although 
the pathogenesis of DDH is not yet fully understood,  
known risk factors are breech presentation,  female 
gender,  primiparity,  ﬁrst born,  swaddling,  multiple 
births,  congenital foot deformities,  high birth weight,  
oligohydramnios and a positive family history of DDH 
[4,  10-13].  However,  the majority of cases have no 
risk factors [14,  15].  The rate of subsequent devel-
opment of hip dysplasia with the existence of one or 
more of these risk factors in infants may range from 
0.1 to 10ｵ [13].  DDH can also be associated with 
other risk factors such as nationality,  congenital 
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Table 1　 Comparison of risk factors between groups
Group I (n : 28)
Mean±SD
Median (25th-75th)
percentile
Group II (n : 43)
Mean±SD
Median (25th-75th)
percentile
P value
MH (cm) 161.25±5.85
161 (157.25-166.50)
164.44±5.46
164 (160-168)
0.022＊　
MW-BP (kg) 58.89±8.76
60 (52.25-65)
58.03±10.82
56 (52-62)
0.361＊＊
IH-B (cm) 48.89±3.02
50 (47-51)
49.26±1.62
49 (48-50)
0.563＊　
IW-B (g) 3,214.82±409.78
3,250 (3,000-3,375)
3,140.93±360.39
3,050 (2,880-3,460)
0.427＊　
M-BMI 22.70±3.53
22.05 (20.30-25.23)
21.45±3.68
21.30 (19.38-22.96)
0.064＊＊
I-BMI 13.48±1.61
13.18 (12.52-14.51)
12.92±1.15
12.82 (12-13.50)
0.143＊＊
MW/MH 36.54±5.40
35.93 (32.56-40.53)
35.26±6.20
34.59 (31.45-37.42)
0.200＊＊
IW/IH 6.57±0.71
6.49 (6.16-6.93)
6.37±0.62
6.18 (5.94-6.85)
0.208＊　
I-BMI/M-BMI 0.61±0.12
0.60 (0.52-0.68)
0.61±0.08
0.61 (0.57-0.67)
0.810＊　
MH/IH 3.31±0.18
3.30 (3.17-3.43)
3.34±0.16
3.33 (3.25-3.42)
0.398＊　
MH/I-BMI 12.13±1.55
12.31 (11.37-12.92)
12.82±1.19
12.77 (12.12-13.79)
0.038＊　
MH,  maternal height; MW-BP,  maternal weight before pregnancy; IH-B,  infant height at birth; IW-B,  infant weight at birth; M-BMI,  
maternal body mass index; I-BMI,  infant body mass index; MW/MH,  maternal weight/maternal height; IW/IH,  infant weight/infant 
height; I-BMI/M-BMI,  infant body mass index/maternal body mass index; MH/IH,  maternal height/infant height; MH/I-BMI,  maternal 
height/infant body mass index.
＊Student t test,  ＊＊Mann-Whitney U test.
muscular torticollis,  or twin pregnancy [16,  17],  or 
with other congenital postural deformities such as 
scoliosis,  talipes equinovarus,  genu recurvatum,  
Potterʼs or compression facies (associated with oligo-
hydramnios),  or plagiocephaly [4].
　 In the present study,  we attempted to eliminate the 
inﬂuence of genetic bias and known mechanical factors 
in DDH,  thereby allowing an in-depth study of the 
inﬂuence of unknown factors (maternal and fetal height 
and weight).  Because a positive family history of DDH 
may be considered genetic bias,  infants with a family 
history of DDH were not included in this study.  The 
ﬁnding that DDH is more common in girls than in boys 
is attributed to greater female sensitivity to the 
maternal hormone relaxin,  which creates ligament 
laxity and allows the hip to subluxate [7].  Therefore,  
only female infants were included in order to eliminate 
the gender risk factor.  In addition,  the incidence of 
DDH may be higher in ﬁrstborns because of increased 
pressure from the abdominal wall [18],  so only ﬁrst-
born infants were included,  and other known mechani-
cal factors were excluded.
　 Some previous studies have examined the associa-
tion between a birth weight of＜2,500g and DDH.  
Low birth weight has been reported to have a protec-
tive eﬀect [4,  13,  19,  20].  In addition,  very low 
birth weight infants have been found not to be at 
increased risk for DDH [21].  In a study by Chan et 
al.  [4],  increasing risk was seen with increasing 
birth weight as infants weighing 4,000-4,499g had an 
OR of 1.55 (1.26,  1.91),  while those weighingｧ4,500g 
had an OR of 2.67 (1.81,  3.94).  In another study,  
Bache et al.  [22] report that infants with a birth 
weight of＞4kg had a two-fold increase in abnormality 
determined by ultrasonography.  It has been reported 
that high birth weight for gestational age is an impor-
tant but minor risk factor for DDH screening policies 
[23].  Most authors report that large,  heavy infants 
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Table 2　 Odds ratio (OR) for risk factors
Odds Ratio 95% CI for odds ratio P value
MH Group I
Group II
0.90
1
0.82-0.99
-
0.027
-
MW-BP Group I
Group II
1.01
1
0.96-1.06
-
0.723
-
IH-B Group I
Group II
0.93
1
0.75-1.15
-
0.508
-
IW-B Group I
Group II
1.01
1
0.99-1.02
-
0.421
-
M-BMI Group I
Group II
1.10
1
0.96-1.26
-
0.166
-
I-BMI Group I
Group II
1.36
1
0.94-1.95
-
0.100
-
MW/MH Group I
Group II
1.04
1
0.96-1.13
-
0.374
-
IW/IH Group I
Group II
1.61
1
0.77-3.40
-
0.208
-
I-BMI/M-BMI Group I
Group II
0.54
1
0.04-70.96
-
0.807
-
MH/IH Group I
Group II
0.28
1
0.02-5.23
-
0.394
-
MH/I-BMI Group I
Group II
0.67
1
0.46-0.99
-
0.044
-
have an increased incidence of DDH [2,  9,  24-27].  
In contrast,  Lambeek et al.  [28] found that birth 
weight was not related to DDH.  Additionally,  Sionek 
et al.  [29] report no statistically signiﬁcant relation-
ship between birth weight and Graf hip joint type.  In 
the present study,  the mean birth weight was 3,250g 
(range,  3,000-3,375g) in Group I and 3,050g (range,  
2,880-3,460g) in Group II.  The mean birth weight in 
Group I was within the normal range.  To the best of 
our knowledge,  there have been no reports on DDH 
that have investigated the motherʼs anthropometric 
characteristics before pregnancy in addition to the 
infantʼs BMI.  The combination of high BMI in the 
fetus with short maternal height may increase the risk 
of DDH through abnormal positioning of the hip joint 
in the intrauterine period.
　 The present study had certain limitations.  First,  
the power analyses for the signiﬁcant parameters were 
smaller than 80ｵ.  It would be ideal to perform a 
multicenter analysis to evaluate the eﬀect of these 
parameters on DDH and increase the power of this 
study.  Second,  this study was limited by its relatively 
small number of subjects.  A larger observational 
study or individual patient data meta-analysis might 
provide the number of patients needed to support or 
reject the hypothesis.
　 The natural history of DDH is not yet fully under-
stood,  and there are many unanswered questions.  
According to the present ﬁndings,  it could be said that 
short maternal height and increased BMI in the fetus 
can be associated with a high incidence of DDH.  To 
the best of our knowledge,  this is the ﬁrst study to 
investigate the relationship between MH and the BMI 
of the fetus.  The precise etiology of DDH remains 
unknown,  but genetic and environmental factors may 
act as internal or external inﬂuences.  Although the 
role of the MH/I-BMI ratio has not yet been fully 
explained,  it may contribute to a greater understand-
ing of the etiology of DDH.  Infants with mothers of 
short stature should be carefully assessed in the neo-
natal period for signs of DDH.  Better phenotypic 
characterization and classiﬁcation will be important 
for future analyses.  In conclusion,  the present results 
suggest that MH and infant BMI should be considered 
risk factors for DDH.  Studies with larger series of 
various population groups are required to conﬁrm and 
expand these ﬁndings as well as to further clarify the 
natural developmental history of hip dysplasia in 
infants.
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